Health Blueprint

Back to Longevity News

News summary

Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by Wissen Research

Source: PR Newswire • Published: 06 Oct 2026, 18:35

Summarized by Masters of Longevity from PR Newswire.

Drug delivery devices trends explained: a market-analysis article outlining how smart, wearable, and connected platforms are reshaping administration options and industry dynamics.

Drug Delivery Devices Market to Reach US$ 698.2 Bn by 2031, Growing at 7.4% CAGR as Smart and Wearable Devices Expand: New Report by Wissen Research
Key Takeaways
  • The market is projected to grow from USD 488.6 billion in 2026 to USD 698.2 billion by 2031.
  • Connected sensors and digital interfaces are expanding injectors, inhalers, and infusion devices into adherence-tracking platforms.
  • Wearable and on-body delivery systems are accelerating adoption for biologics, diabetes care, immunotherapy, and oncology.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.